
CJC-1295 (with DAC)
Long-acting GHRH analogue that supports sustained GH elevation and fat metabolism.
CJC-1295 (with DAC)
CJC-1295 with DAC (Drug Affinity Complex) is a long-acting synthetic analogue of growth hormone-releasing hormone (GHRH) that achieves an extended plasma half-life through covalent binding to circulating albumin via a reactive maleimide group. While CJC-1295 (No DAC) produces pulsatile GH release, the DAC version provides sustained, continuous GHRH receptor stimulation for prolonged GH axis support.
How It Works
CJC-1295 with DAC binds to GHRH receptors on pituitary cells, activating adenylyl cyclase and driving GH synthesis and release. The DAC component enables albumin binding, extending half-life to approximately 6–8 days:
• Sustained GH Elevation:: Extended half-life produces sustained GH levels rather than discrete pulses
• Continuous IGF-1 Support:: Sustained GH elevation drives continuous hepatic IGF-1 production
• Fat Metabolism:: Sustained GH/IGF-1 elevation supports lipid metabolism, triglyceride hydrolysis, and visceral fat mobilization
• Protein Synthesis:: Continuous IGF-1 elevation activates mTOR-dependent protein synthesis pathways
• Body Composition:: Supports lean mass while promoting fat metabolism over extended periods
Key Benefits
• Long-Acting:: Once-weekly or less frequent dosing due to extended half-life
• Sustained GH Support:: Continuous GH axis activation for comprehensive metabolic support
• Fat Metabolism:: Supports sustained fat mobilization and body composition improvement
• Lean Mass:: Continuous IGF-1 support for protein synthesis and lean mass maintenance
Structural Properties
CJC-1295 with DAC has a molecular weight of 3647.1 Da (CAS: 863288-34-0). The DAC maleimide group enables covalent albumin binding. Purity ≥98.5%.
Quality and Purity
Supplied as a lyophilized powder with purity ≥98.5% verified by HPLC and mass spectrometry. Each vial contains 2 mg.
Storage
Store at −20°C. Stable for 24 months.
Product Details
Storage & Handling
Store at -20°C.
Related Products

MOTS-c
Mitochondrial peptide that activates AMPK for fat metabolism and metabolic health.
LEAP2 Peptide
Endogenous ghrelin receptor antagonist supporting appetite suppression and fat metabolism.